Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.
about
Emerging drugs for small cell lung cancer--an update.Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer.Chemotherapy advances in small-cell lung cancerTherapeutic potential and molecular mechanism of a novel sulfonamide anticancer drug, indisulam (E7070) in combination with CPT-11 for cancer treatment.
P2860
Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.
@ast
Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.
@en
Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.
@nl
type
label
Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.
@ast
Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.
@en
Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.
@nl
prefLabel
Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.
@ast
Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.
@en
Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.
@nl
P2093
P2860
P356
P1476
Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.
@en
P2093
Kazuto Hirata
Shinzoh Kudoh
Tatsuo Kimura
P2860
P356
10.4137/CMO.S5072
P407
P577
2011-03-03T00:00:00Z